Duration of action of two insulin glargine products LY2963016 insulin glargine and Lantus insulin glargine in subjects with type 1 diabetes mellitus

摘要

Aims LY2963016 (LY IGlar) and Lantus (IGlar) are insulin glargine products manufactured by distinct processes, but with identical amino acid sequences. This study compared the duration of action of LY IGlar and IGlar in subjects with type 1 diabetes mellitus (T1DM).